594 SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16+ tumors treated with cell-based vaccine, SQZ-PBMC-HPV

• Neesha Dhani,
• Antonio Jimeno,
• Michael S Gordon,
• Matthew H Taylor,
• Howard Bernstein,
• Scott Loughhead,
• Joaquina Baranda,
• Udo Holtick,
• Jong Chul Park,
• Wade T Iams,
• Monica MitaSc,
• Kerry J Rodabaugh,
• E Amanda Duvall,
• Julia Jennings,
• Nathan Miselis,
• Marshelle S Warren

Affiliations

Neesha Dhani

2Laboratory Medicine Program, Department of Medical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada

Antonio Jimeno

Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

Michael S Gordon

HonorHealth Research Institute, Scottsdale, Arizona, USA

Matthew H Taylor

Department of Internal Medicine, Seoul National University College of Medicine, Seongnam, Republic of Korea

Howard Bernstein

SQZ Biotechnologies, Watertown, MA, USA

Scott Loughhead

SQZ Biotechnologies, Watertown, MA, USA

Joaquina Baranda

11University of Kansas Cancer Center, Fairway, KS, USA

Udo Holtick

4Department I of Internal Medicine, Medical Faculty, University of Cologne, Cologne, Germany

Jong Chul Park

1Massachusetts General Hospital, Boston, MA, USA

Wade T Iams

9Vanderbilt University Medical Center, Nashville, TN, USA

Monica MitaSc

4Cedars-Sinai Medical Center, Los Angeles, CA, USA

Kerry J Rodabaugh

7University of Nebraska Medical Center, Omaha, NE, USA

E Amanda Duvall

10SQZ Biotechnologies, Watertown, MA, USA

Julia Jennings

10SQZ Biotechnologies, Watertown, MA, USA

Nathan Miselis

10SQZ Biotechnologies, Watertown, MA, USA

Marshelle S Warren

10SQZ Biotechnologies, Watertown, MA, USA